Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-16

FDA Approved: ACETAZOLAMIDE — Supplemental Application (Eywa Pharma Inc)

View source ↗

Summary

The FDA approved Eywa Pharma Inc's supplemental application for acetazolamide, enabling continued marketing of a generic acetazolamide product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

SUPPL AP for ACETAZOLAMIDE (ACETAZOLAMIDE)